EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway

Pongsakorn Taweesap, Prapassorn Potue iD, Juthamas Khamseekaew, Metee Iampanichakul iD, Banyaphon Jan-O, Poungrat Pakdeechote iD, Putcharawipa Maneesai iD

International Journal of Molecular Sciences · 17.04.2025 · 26 (8) · 3804

DOI: 10.3390/ijms26083804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.04.2025. Verfasst von Pongsakorn Taweesap und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. Hauptthemen laut MEDLINE: Luteolin, PPAR gamma, Diet, High-Fat, Receptors, Adiponectin. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Fundamental Research Fund (which has received funding support from the National Science, Research and Innovation Fund, or "NSRF…, The Invitation Research Fund (IN67044), Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Fundamental Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant global public health issue. Luteolin possesses several beneficial biological properties, including antioxidation and anti-inflammation. This study investigated luteolin’s effect and potential mechanisms on MAFLD in high-fat diet (HFD)-fed rats. Rats were administered an HFD supplemented with fructose for 12 weeks to induce MAFLD. After that, the HFD-fed rats were given either luteolin (50 or 100 mg/kg/day) or metformin (100 mg/kg/day) for 4 weeks. Luteolin improved metabolic parameters induced by the HFD, since it decreased body weight, blood pressure, fasting blood glucose, serum insulin, free fatty acids, cholesterol, and triglyceride levels (p < 0.05). Luteolin reduced hepatic injury and inflammatory markers in HFD-fed rats (p < 0.05). Additionally, HFD-fed rats treated with luteolin showed reduced malondialdehyde and raised catalase activity in plasma (p < 0.05). Luteolin attenuated hepatic steatosis compared to the untreated rats (p < 0.05). Luteolin also increased plasma adiponectin levels accompanied by upregulation of adiponectin receptor 1 (AdipoR1), AMP-activated protein kinase (AMPK), and peroxisome proliferator-activated receptor γ (PPAR-γ) protein expression in liver (p < 0.05). These findings revealed that luteolin ameliorated HFD-induced MAFLD in rats, possibly by reducing metabolic alterations and oxidative stress and restoring AdipoR1, AMPK, and PPARγ protein expression in HFD-fed rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinPPAR gammaDiet, High-FatReceptors, AdiponectinSignal TransductionAMP-Activated Protein KinasesFatty LiverNon-alcoholic Fatty Liver DiseaseAnimalsRatsMaleLiverOxidative StressRats, Sprague-DawleyAdiponectin

Stichwörter der Autor:innen

AdipoR1MAFLDPPARγhepatic steatosishigh-fat dietluteolin

Substanzen

LuteolinPPAR gammaReceptors, AdiponectinAMP-Activated Protein Kinasesadiponectin receptor 1, ratPPAR gamma, ratAdiponectin

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

ORCID-Profile: Prapassorn Potue, Metee Iampanichakul, Poungrat Pakdeechote, Putcharawipa Maneesai

Förderung

  • This study was supported by the Fundamental Research Fund (which has received funding support from the National Science, Research and Innovation Fund, or "NSRF…
  • The Invitation Research Fund (IN67044), Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Fundamental Research Fund
  • Research and Graduate Study, Khon Kaen University, and the Invitation Research Fund
  • Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
  • Development and Promotion of Science and Technology Talents Project (DPST)

Zitieren

APA

Taweesap, P., Potue, P., Khamseekaew, J., Iampanichakul, M., Jan-O, B., Pakdeechote, P., & Maneesai, P. (2025). Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway. International Journal of Molecular Sciences, 26(8), 3804. https://doi.org/10.3390/ijms26083804

Vancouver

Taweesap P, Potue P, Khamseekaew J, Iampanichakul M, Jan-O B, Pakdeechote P, et al. Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway. International Journal of Molecular Sciences. 2025;26(8):3804. doi:10.3390/ijms26083804

BibTeX
@article{Taweesap2025,
  author = {Taweesap, Pongsakorn and Potue, Prapassorn and Khamseekaew, Juthamas and Iampanichakul, Metee and Jan-O, Banyaphon and Pakdeechote, Poungrat and Maneesai, Putcharawipa},
  title = {Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {8},
  pages = {3804},
  doi = {10.3390/ijms26083804}
}
Kostenlos starten →